ImmunityBio, Inc. IBRX Common stock issuance discount related to revenue interest liability
Common stock issuance discount related to revenue interest liability at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept ibrx:CommonStockDiscountOnSharesRevenueInterestLiability.
The official record: ImmunityBio, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s common stock issuance discount related to revenue interest liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s common stock issuance discount related to revenue interest liability?
- ImmunityBio, Inc. (IBRX) reported common stock issuance discount related to revenue interest liability of $0 in Q4 2025.
- What does common stock issuance discount related to revenue interest liability mean?
- This represents the discount applied to common stock issued in connection with revenue interest liabilities or royalty-based financing. It reflects the cost of capital associated with non-traditional financing arrangements.